JONATHAN GARCELLANO: Open Payments
NPI 1659955433 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 6 payments from 5 companies in 2025. Trend: 2023 $906 · 2024 $260 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $146 |
| Amgen Inc. | 1 | $138 |
| ABIOMED | 1 | $126 |
| Corcept Therapeutics | 1 | $123 |
| Smith+Nephew, Inc. | 1 | $24 |
Products named: Livdelzi, Korlym, STRAVIX PL.
Industry payments across TX — which companies pay providers there.
